Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1445-2197.2007.04199.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comparison of PKRP and TUVP in the treatment of high-risk BPH and analysis of postoperative influencing factors.
Front Surg
August 2022
Department of Urology Surgery, Shunyi Hospital, Beijing, China.
Objective: This study aims to compare the efficacy of plasma kinetic loop resection of the prostate (PKRP) and transurethral vaporization of the prostate (TUVP) for the treatment of high-risk benign prostatic hyperplasia (BPH), and analyze the influence of the related factors on the operation of BPH.
Methods: A total of 108 high-risk BPH patients diagnosed in our hospital from March 2018 to September 2021 were selected and randomly divided into an observation group and a control group, with 54 cases in each group. The control group was treated with TUVP, and the observation group was treated with PKRP.
Recent advances in prostatectomy for benign prostatic hyperplasia.
F1000Res
May 2020
Weill Medical College of Cornell University, Ithaca, NY, USA.
This review provides a brief overview of and commentary on currently available technology for the surgical treatment of obstructive benign prostatic hyperplasia causing lower urinary tract symptoms. This review provides references relevant to review and understand current technology that is clinically available.
View Article and Find Full Text PDFPure Bipolar Plasma Vaporization of the Prostate: Results from a Prospective 3D Ultrasound Volumetry Study with Clinical Outcome After 3 Years.
J Endourol
February 2019
Department of Urology, University Hospital Zürich, University of Zürich, Zürich Switzerland.
Introduction And Objectives: Bipolar plasma vaporization (BPV) has been shown to be a low-morbidity alternative to conventional transurethral resection of the prostate (TURP). Improved functional short-term outcome and a postoperative prostate volume reduction comparable to TURP have been reported. However, comprehensive mid- or long-term results following BPV are still lacking.
View Article and Find Full Text PDFManagement of greenlight laser plus transurethral resection of prostate for elderly men.
Medicine (Baltimore)
August 2018
Department of Urology, Tianjin Union Medical Center, Hong-qiao District, Tianjin, China.
The study is aiming to evaluate the treatment safety and efficacy of greenlight laser photovaporization of the prostate (PVP) combined with transurethral electrovaporization resection (TUVP) for elderly (≥ 70 years) men with lower urinary tract symptoms due to benign prostatic hyperplasia (BPH/LUTS) with a large prostate volume (≥ 80 mL). One hundred twelve BPH/LUTS patients treated with PVP were divided into 2 groups according to prostate volume (PV), the outcomes of the 2 groups were assessed at 12 months after the operation. Patients in the PV ≥ 80 group (n = 51) had a higher level of maximum detrusor pressure (Pdet.
View Article and Find Full Text PDF[Transurethral diode laser enucleation versus transurethral electrovaporization resection of the prostate for benign prostatic hyperplasia with different prostate volumes].
Zhonghua Nan Ke Xue
March 2017
Department of Urology, The Second People's Hospital of Lianyungang, Lianyungang, Jiangsu 222000, China.
Objective: To compare the clinical effect of diode laser enucleation of the prostate (DIOD) with that of transurethral resection of the prostate (TURP) on benign prostate hyperplasia (BPH) with different prostate volumes.
Methods: This retrospective study included 256 BPH patients treated by DIOD (n = 141) or TURP (n = 115) from March 2012 to August 2015. According to the prostate volume, we divided the patients into three groups: <60 ml (42 for DIOD and 31 for TURP), 60－80 ml (51 for DIOD and 45 for TURP), and >80 ml (48 for DIOD and 39 for TURP).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!